HMGB1 AS A PROGNOSTIC BIOMARKER IN THE PROGRESSION OF BARRETT'S OESOPHAGUS

被引：0
|
作者：
Porter, R. [1 ]
Murray, G. I. [1 ]
Petty, R. [2 ]
El-Omar, E. M. [1 ]
Hold, Gl [1 ]
McLean, M. H. [1 ]
机构：
[1] Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen, Scotland
[2] Univ Dundee, Med Res Inst, Div Canc Res, Dundee, Scotland
来源：
GUT | 2016年 / 65卷
关键词：
D O I：
10.1136/gutjnl-2016-312388.239
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PTU-154
引用
收藏
页码：A133 / A133
页数：1
相关论文
共 50 条
  • [1] Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype
    Ross J. Porter
    Graeme I. Murray
    Daniel P. Brice
    Russell D. Petty
    Mairi H. McLean
    [J]. British Journal of Cancer, 2020, 122 : 545 - 554
  • [2] Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotype
    Porter, Ross J.
    Murray, Graeme I.
    Brice, Daniel P.
    Petty, Russell D.
    McLean, Mairi H.
    [J]. BRITISH JOURNAL OF CANCER, 2020, 122 (04) : 545 - 554
  • [3] Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
    Liikanen, Ilkka
    Koski, Anniina
    Merisalo-Soikkeli, Maiju
    Hemminki, Otto
    Oksanen, Minna
    Kairemo, Kalevi
    Joensuu, Timo
    Kanerva, Anna
    Hemminki, Akseli
    [J]. ONCOIMMUNOLOGY, 2015, 4 (03): : 1 - 13
  • [4] HMGB1 as biomarker and drug target
    Venereau, Emilie
    De Leo, Federica
    Mezzapelle, Rosanna
    Careccia, Giorgia
    Musco, Giovanna
    Bianchi, Marco E.
    [J]. PHARMACOLOGICAL RESEARCH, 2016, 111 : 534 - 544
  • [5] Hallmarks of cancer progression in Barrett's oesophagus
    Morales, CP
    Souza, RF
    Spechler, SJ
    [J]. LANCET, 2002, 360 (9345): : 1587 - 1589
  • [6] Molecular changes in the progression of Barrett's oesophagus
    Zagorowicz, Edyta
    Jankowski, Janusz
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (982) : 529 - 535
  • [7] Role of HMGB1 in tumor progression
    Yanai, Hideyuki
    Kimura, Yoshitaka
    Taniguchi, Tadatsugu
    [J]. CANCER SCIENCE, 2018, 109 : 73 - 73
  • [8] C-MYC AS A BIOMARKER IN BARRETT'S OESOPHAGUS
    Varghese, S.
    Ross-Innes, C. S.
    Lao-Sirieix, P.
    O'Donovan, M.
    Fitzgerald, R. C.
    [J]. GUT, 2013, 62 : A119 - A119
  • [9] Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma - a possible biomarker to predict the malignant potential of Barrett's oesophagus
    Iwaya, Yugo
    Hasebe, Osamu
    Koide, Naohiko
    Kitahara, Kei
    Suga, Tomoaki
    Shinji, Akihiro
    Muraki, Takashi
    Yokosawa, Shuichi
    Yamada, Shigenori
    Arakura, Norikazu
    Tanaka, Eiji
    Nakayama, Jun
    [J]. HISTOPATHOLOGY, 2014, 64 (04) : 536 - 546
  • [10] Reappraisal of oxidized HMGB1 as a mediator and biomarker
    Pirnie, Ross
    Gillespie, Kevin P.
    Mesaros, Clementina
    Blair, Ian A.
    [J]. FUTURE SCIENCE OA, 2022, 8 (10):
12345